NSE - Delayed Quote INR

Gland Pharma Limited (GLAND.NS)

Compare
1,782.05
-47.90
(-2.62%)
At close: January 10 at 3:29:54 PM GMT+5:30
All numbers in thousands
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
106,612,460.00
87,775,350.00
78,336,210.00
64,960,820.00
Total Liabilities Net Minority Interest
19,374,030.00
8,188,130.00
6,760,000.00
5,928,400.00
Total Equity Gross Minority Interest
87,238,430.00
79,587,220.00
71,576,210.00
59,032,420.00
Total Capitalization
88,303,830.00
79,619,830.00
71,614,420.00
59,071,760.00
Common Stock Equity
87,238,430.00
79,587,220.00
71,576,210.00
59,032,420.00
Capital Lease Obligations
523,840.00
6,320.00
8,100.00
9,260.00
Net Tangible Assets
83,693,650.00
79,470,610.00
71,450,860.00
59,032,420.00
Working Capital
42,467,890.00
61,716,750.00
52,700,540.00
46,111,140.00
Invested Capital
90,436,250.00
79,625,430.00
71,615,540.00
59,073,110.00
Tangible Book Value
83,693,650.00
79,470,610.00
71,450,860.00
59,032,420.00
Total Debt
3,721,660.00
44,530.00
47,430.00
49,950.00
Share Issued
164,710.52
164,700.82
164,302.72
163,592.92
Ordinary Shares Number
164,710.52
164,700.82
164,302.72
163,592.92
3/31/2021 - 11/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers